The U.S. Food and Drug Administration has declined to approve a novel epinephrine nasal spray to treat allergic reactions. Instead,… Read more »
Author: Jenifer Goodwin and Gwen Smith
AAAAI News: Dupilumab Remission; Tezepelumab in Severe Asthma; Palforzia Safety
Dupilumab Led to Asthma Remission for Some About 30 percent of patients taking the biologic drug dupilumab experienced “remission” of… Read more »
U.K. Allergy Warning on Pfizer COVID Vaccine Ignites Fears
Updated Dec. 10, 2020 – The British regulator of medicines has set off alarm bells in the allergy community by… Read more »